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The wide implementation of next-generation sequencing (NGS) technologies has
revolutionized the field of medical genetics. However, the short read lengths of currently
used sequencing approaches pose a limitation for the identification of structural variants,
sequencing repetitive regions, phasing of alleles and distinguishing highly homologous
genomic regions. These limitations may significantly contribute to the diagnostic gap in
patients with genetic disorders who have undergone standard NGS, like whole exome or
even genome sequencing. Now, the emerging long-read sequencing (LRS) technologies
may offer improvements in the characterization of genetic variation and regions that are
difficult to assess with the prevailing NGS approaches. LRS has so far mainly been used
to investigate genetic disorders with previously known or strongly suspected disease
loci. While these targeted approaches already show the potential of LRS, it remains to
be seen whether LRS technologies can soon enable true whole genome sequencing
routinely. Ultimately, this could allow the de novo assembly of individual whole genomes
used as a generic test for genetic disorders. In this article, we summarize the current
LRS-based research on human genetic disorders and discuss the potential of these
technologies to facilitate the next major advancements in medical genetics.
Keywords: long-read sequencing, next-generation sequencing, medical genetics, structural variation, tandem
repeat expansion, phasing, pseudogenes
INTRODUCTION
Since its introduction over a decade ago, next-generation sequencing (NGS) of DNA has become
a routine diagnostic tool for modern medical genetics and revolutionized the discovery of novel
Mendelian disease genes (Gilissen et al., 2011). Due to the high-throughput nature and low costs of
NGS compared to Sanger sequencing, previous single gene approaches have largely been replaced
by gene panels and whole exome sequencing (WES), allowing better clinical diagnostics (Gilissen
et al., 2011; Goodwin et al., 2016). However, despite the numerous advancements that NGS has
conferred, many studies are still hindered by the short-read lengths (∼150–300 bp) that the current
NGS technologies are bound to use in order to preserve high read quality (Goodwin et al., 2016).
Issues arising from the use of short reads can mainly be pinned down to the highly repetitive and
complex nature of the human genome (Feuk et al., 2006; de Koning et al., 2011; Treangen and
Salzberg, 2011). It has been shown that despite the use of sophisticated bioinformatic algorithms
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it is often impossible to accurately map, or even assemble, short
reads originating from regions harboring structural variation
(SV), repetitive sequences, extreme guanine-cytosine (GC)
content, or sequences with multiple homologous elements within
the genome (Salzberg and Yorke, 2005; Treangen and Salzberg,
2011). This introduces errors in calling genetic variants and
inability to capture certain genomic regions (Ashley, 2016).
Furthermore, with short-read NGS (SR-NGS) the variant phasing
information is often lost (Delaneau et al., 2013) and the data
analysis is highly dependent on the reference genomes, which are
known to be imperfect (Genovese et al., 2013). The dependency
on the reference genome is especially problematic for the
detection of SVs at complex genomic regions that can be highly
individual- or population-specific (Chaisson et al., 2015b).
Genetics research has always been strongly driven by novel
sequencing technologies, first by Sanger sequencing and later
followed by NGS (Shendure et al., 2017). With the recently
demonstrated success in identifying previously intractable DNA
sequences and closing gaps in the human genome assemblies
(Chaisson et al., 2015a; Seo et al., 2016; Shi et al., 2016; Jain et al.,
2018), long-read sequencing (LRS) technologies hold the promise
to overcome specific limitations of NGS-based investigations of
human diseases. The main advantage of LRS compared to other
platforms stems from the use of long-reads (>10 kilobase [kb]
on average), originating from single DNA molecules (van Dijk
et al., 2018). Moreover, the sequencing process occurs in real-time
and both the sequencing and library preparation are conducted
without the need of PCR amplification, therefore being free from
any PCR related bias (Schadt et al., 2010). The absence of PCR
leaves the DNA in its native state, enabling LRS technologies to
directly detect base modifications, such as methylation (Flusberg
et al., 2010; Laszlo et al., 2013).
Attributable to these features, LRS has the potential to grow
into a technology that is used not only to produce high-quality
genome assemblies (i.e., the platinum human reference genome)
(Chaisson et al., 2015a; Pollard et al., 2018), but also to capture
clinically relevant genomic elements which are problematic for
conventional approaches (summarized in Figure 1). This has
been shown in several studies by (1) identifying disease causing
SVs that SR-NGS might not detect, (2) directly sequencing repeat
expansions and regions with extreme GC-content, (3) resolving
variant phasing and (4) distinguishing a gene of interest from its
pseudogenes (Table 1). Importantly, recent studies have indicated
that LRS technology may play an important role in discovering
novel pathogenic mutations in human diseases with previously
unknown genetic causes (Aneichyk et al., 2018; Ishiura et al.,
2018; Zeng et al., 2018) and open up unprecedented opportunities
to investigate transcriptomics (Byrne et al., 2017). In the future,
this technology could ultimately allow whole genome sequencing
(WGS) and even de novo assembly capturing all variant types
present in individual genomes, independently of the reference
genome limitations (Chaisson et al., 2015b). In this review, we
summarize the LRS-based research of human genetic diseases
and discuss the future promise of these technologies to enable
the next major advancements in medical genetics. We focus on
the prevailing true LRS methods that have been commercially
released so far; single molecule real-time (SMRT) sequencing by
Pacific Biosciences (PacBio) and nanopore sequencing by Oxford
Nanopore Technologies Inc. (ONT) (Clarke et al., 2009; Eid et al.,
2009) (Box 1 for technical summary).
OVERCOMING CURRENT LIMITATIONS
IN MEDICAL GENETICS
Whole exome sequencing (WES), mainly using Illumina
platforms, is often used as a first-tier test for many genetic
diseases. This has been very successful and has brought genetic
testing and diagnostics into a whole new era (Gilissen et al., 2011).
However, for many patients that have undergone diagnostic WES,
or even WGS, the underlying cause of their disease remains
unsolved (Gilissen et al., 2014). Curiously, the recent WGS
studies applying LRS have revealed that each human genome
harbors >20,000 of SVs (>50 bp) and additional thousands
of indels (<50 bp), spanning dozens of megabases (Mbs), that
have largely remained undetected with conventional SR-NGS
(Chaisson et al., 2015b, 2019; Pendleton et al., 2015; Seo et al.,
2016; Shi et al., 2016; Huddleston et al., 2017; De Coster
et al., 2018). In patients with suspected genetic diseases, such
hidden SVs and indels may well disrupt relevant genes or
cause a dosage change for dosage-sensitive genes. Furthermore,
NGS methods heavily rely on PCR, which leads to GC-content
dependent coverage bias (Benjamini and Speed, 2012). Low or
zero coverage at genomic locations with extreme GC-contents
are estimated to span >150 Mb of gene-rich regions (Genomes
Project Consortium et al., 2012) and some of those may as
well account for a proportion of the hidden genetic variation
underlying human diseases. Among the approaches that are
based on SR-NGS, the PCR-free library preparation methods
provide the most uniform genome coverage and may allow
sequencing of some of the previously difficult regions (Dolzhenko
et al., 2017). However, SR-NGS always requires a PCR-step in
the template amplification, e.g., bridge-PCR, which may still
introduce a sequencing bias.
In contrast to the contemporary SR-NGS methods, LRS
technologies require no PCR amplification and sequencing is
performed on single molecules instead of colonies or clusters of
amplified DNA molecules, resulting in a more evenly distributed
coverage (Schadt et al., 2010). This, together with longer reads
that can span over challenging genomic regions and SVs, may
offer an unprecedented view on previously poorly characterized
genomic locations (Chaisson et al., 2015a; Jain et al., 2018)
and eventually improve the variant calling of population-scale
sequencing data (Ameur et al., 2018a). While increases in the
throughput and lower prices may in the future allow more long-
read WGS for individual patients, targeted approaches are already
demonstrating the value of LRS for medical genetics (Tables 1, 2)
(Ameur et al., 2018b).
Detection and Characterization of
Structural Variation
High-depth sequencing by NGS is a reliable and cost-efficient
method for detecting single nucleotide variants (SNVs) and
small indels (Ashley, 2016; Goodwin et al., 2016). However,
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FIGURE 1 | Overview of the main advantages of current long-read sequencing (LRS) approaches in medical genetics. The predominant difference between LRS and
the conventional SR-NGS approaches is the significant increase in read length. In contrast to short reads (150–300 bp), LRS has the capacity to sequence on
average over 10 kb in one single read, thereby requiring less reads to cover the same gene (illustrated in top panel). Hence, aside from reducing alignment and
mapping errors, LRS holds various advantages over short-read approaches which can greatly impact medical genetics (bottom panel). (1) Improved detection and
characterization of large structural variation (SV), due to, e.g., large inversions or translocations. (2) Capacity to directly, and with that more accurately, sequence over
long tandem repeat expansions and extreme GC-rich regions. (3) Enhanced phasing, i.e., assignment of genetic variants to the homologous paternal or maternal
chromosomes, to determine inheritance patterns, parental origin of de novo events, mosaicism, allele specific expression and disease risk haplotypes. (4) Improved
discrimination of clinically relevant genes from their pseudogenes.
in the detection of larger genomic deletions, duplications and
rearrangements, SR-NGS approaches often lack sensitivity, show
excess of false positives and misinterpret complex SVs (Tattini
et al., 2015; Ashley, 2016; Huddleston et al., 2017; Sedlazeck et al.,
2018b). Yet, SVs >50 bp in size are an important source of
genetic variation, accounting for the greatest number of divergent
bases across human genomes (Alkan et al., 2011; Sudmant et al.,
2015; Chaisson et al., 2019). Moreover, SMRT sequencing of a
haploid human genome has shown that as much as 89% of the
identified variation, consisting mainly of SVs, had been missed
in the 1000 genomes project (Huddleston et al., 2017). Similarly,
a sevenfold increase in SV detection was achieved by a multi-
platform approach, including LRS, compared to standard SR-
NGS methods (Chaisson et al., 2019). It is likely that this gain
in SV detection sensitivity is due to the different sequencing
technology itself, as this benefits from longer fragments, no PCR,
and less sequence bias.
The detection of SVs by SR-NGS is indirect and based on
read depth coverages and use of paired-end reads, for which the
approximate length between read pairs is known (Tattini et al.,
2015). For copy number variants (CNVs), the excess of reads
can indicate amplification whereas the loss of reads is suggestive
for a deletion. Rearrangements can be discovered using paired-
end reads by investigating deviations in the expected distances
and orientations between read pairs (Tattini et al., 2015). In
contrast to SR-NGS, the long reads obtained with PacBio or ONT
sequencers are more likely to span SV breakpoints, or often the
entire SV event, with high-confidence alignments (Huddleston
et al., 2017; De Coster et al., 2018; Sedlazeck et al., 2018b).
Furthermore, longer reads can be more confidently aligned to
repetitive sequences that often mediate the formation of SVs
(Sedlazeck et al., 2018b). Long reads also allow better distinction
of haplotypes, further contributing to the accuracy of analyzing
SVs (Seo et al., 2016; Cretu Stancu et al., 2017). Other methods,
such as microarray copy number profiling and karyotyping, have
traditionally been used to detect disease causing SVs. However,
with these approaches it is not possible to map small or copy-
balanced SVs, and they do not provide accuracy at base-pair
resolution, nor the possibility to resolve complex SVs (Alkan
et al., 2011). Thus, LRS can substantially increase the resolution
and reliability of SV detection and mapping.
Recently, Cretu Stancu et al. (2017) proposed LRS as an
alternative approach for genome-wide detection of clinically
relevant SVs and used ONT-WGS to analyze two patients
with congenital abnormalities caused by de novo chromothripsis
rearrangements. The authors demonstrated that long reads, even
with a relatively low coverage of 16×, are superior to short reads
(WGS with average coverage of∼30×) in detecting and mapping
the breakpoints of the rearrangements. The improved phasing
capability with long reads also enabled the determination of the
parental origin of these de novo events (Cretu Stancu et al., 2017).
Other studies have demonstrated the potential benefits of LRS
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TABLE 1 | Human genetic diseases investigated with LRS technologies.
Phenotype Technology Finding Reference(s)
Identification and fine-mapping of structural variation
Developmental disorder ONT Complex rearrangements
(chromothripsis)
Cretu Stancu et al., 2017
Carney complex SMRT Large deletion (PRKAR1A) Merker et al., 2018
Bardet–Biedl syndrome SMRT Large deletion (BBS9) Reiner et al., 2018
Glycogen storage disease IA ONT Large deletion (G6PC) Miao et al., 2018
Developmental disorder ONT Chromosomal translocation Dutta et al., 2018
X-linked Parkinsonism SMRT and 10× genomics SVA insertion (TAF1) Aneichyk et al., 2018
Sequencing over tandem repeat expansion loci
Fragile-X SMRT Repeat expansion length and
interruption motifs (FMR1)
Loomis et al., 2013; Ardui et al., 2017;
Ardui et al., 2018b
SCA10 and Parkinson’s disease SMRT Repeat expansion length and
interruption motifs (ATXN10)
Schule et al., 2017; McFarland et al.,
2015
ALS and FTD SMRT and ONT Repeat expansion length (C9orf72) Ebbert et al., 2018
Huntington’s disease SMRT Repeat expansion length and somatic
variability (HTT )
Hoijer et al., 2018
Myotonic dystrophy 1 SMRT Repeat expansion length, interruption
motifs and somatic variability (DMPK)
Cummings et al., 2017
BAFME and FCMTE SMRT and ONT Novel repeat expansion loci (SAMD12,
TNRC6A, and RAPGEF2)
Ishiura et al., 2018; Zeng et al., 2018
Alzheimer’s disease ONT ABCA7 repeat expansion length and
alternative sequence motifs
De Roeck et al., 2017
Resolving allele phasing
KID syndrome SMRT Revertant mosaicism (CX26) Gudmundsson et al., 2017
Treacher Collins and Noonan syndrome SMRT Parental origin of de novo mutations
(TCOF1 and PTPN11)
Wilbe et al., 2017
Discriminating pseudogenes
ADPKD SMRT Pseudogene discrimination (PKD1) Borras et al., 2017
Primary immunodeficiency SMRT Pseudogene discrimination (IKBKG) Frans et al., 2018
Drug metabolism SMRT and ONT Pseudogene discrimination and allele
phasing (CYP2D6)
Ammar et al., 2015; Qiao et al., 2016;
Buermans et al., 2017
ADPKD, autosomal dominant polycystic kidney disease, ALS, amyotrophic lateral sclerosis; BAFME, benign adult familial myoclonic epilepsy; FCMTE, familial cortical
myoclonic tremor with epilepsy; FTD, frontotemporal dementia; KID, Keratitis-ichthyosis-deafness; SCA10, spinocerebellar ataxia type 10; SVA, SINE-VNTR-Alu
retrotransposon.
over standard SR-NGS in clinical diagnostics to detect pathogenic
SVs. In a study by Merker et al. (2018), a patient with clinically
diagnosed Carney complex had previously received negative test
results from diagnostic gene panel sequencing and WGS. In
contrast, low-coverage SMRT-WGS successfully identified the
causative heterozygous deletion of over 2 kb overlapping the first
exon of PRKAR1A (Merker et al., 2018). Similarly, Miao et al.
(2018) explored ONT-WGS to confirm the diagnosis for a patient
with recessive glycogen storage disease by identifying a second-
hit (∼7 kb deletion) in G6PC, which had remained undetected
in previous WES analysis. Together, these studies indicate that
LRS has the ability to surpass conventional NGS-methods in the
detection of SVs and yield clinical diagnoses at a molecular level
in previously unsolved cases.
The fine-mapping of SVs at single-nucleotide resolution
is important for patients in which translocation or inversion
breakpoints disrupt disease causing genes (Chen et al., 2010). For
this, long reads are highly beneficial and may render mapping
by laborious amplicon-based Sanger sequencing obsolete, as
demonstrated by Reiner et al. (2018) who used SMRT to fine-
map BBS9 deletion in a patient with Bardet–Biedl syndrome.
In another diagnostic case-study, ONT-WGS was able to track
down the exact breakpoints of a reciprocal translocation, which
led to the identification of disrupted ARHGEF9 gene in a girl with
intellectual disability (Dutta et al., 2018).
In addition to the improved identification and mapping of
SVs affecting known disease genes, we are now seeing the
first discoveries of novel disease genes harboring SVs that
are characterized with LRS technologies. As an outstanding
example, an unbiased de novo assembly using LRS (SMRT and
synthetic longs reads with 10× Genomics) was important for
the identification of SINE-VNTR-Alu insertion in TAF1, a newly
discovered gene for X-linked Dystonia Parkinsonism (Aneichyk
et al., 2018). While multiple studies indicate that LRS is superior
to SR-NGS in the discovery of SVs, it is also shown that once
the alternate allele is resolved, many of these events (∼61%) can
be genotyped with high accuracy and lower costs using SR-NGS
(Huddleston et al., 2017). This shows that part of the missed SVs
are present in the SR-NGS data and therefore improved software
may still provide a more complete picture of genomes sequenced
with short reads. It is noted that the current cut-off of 50 bp
for SVs is arbitrary; indels <50 bp are also identified by LRS
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BOX 1 | Technical summary of LRS technologies.
True versus synthetic LRS
The current LRS technologies can be divided into true LRS and synthetic LRS technologies. In synthetic LRS approaches the long stretches of DNA are linked by
molecular barcodes, which is followed by sequencing with conventional short-reads and in silico construction of the original DNA molecule (Goodwin et al., 2016).
Usually these methods rely on serial-dilutions of very long DNA fragments and physical separation before library preparation in which molecule specific barcodes are
added (Kitzman et al., 2011; Peters et al., 2012; Kuleshov et al., 2014). Similar technologies have recently been further optimized and commercialized by 10×
Genomics Inc. (Weisenfeld et al., 2017). These technologies have already provided haplotype aware SR-WGS (Zheng et al., 2016) and improved SV calling from
SR-WGS data (Nazaryan-Petersen et al., 2018; Marks et al., 2019). While synthetic long-reads leverage advantages of LRS, some short-read issues may persist,
e.g., PCR-bias and intra-read complexity may not always be fully resolved.
SMRT sequencing by PacBio
As a first commercial platform for LRS, PacBio released the RS sequencer in 2011, which was followed by RSII in 2013 and Sequel in 2015. SMRT technology is
based on special flow cells harboring individual picolitre-sized wells with transparent bottoms. Each of the wells, referred to as zero mode waveguides (ZMW),
contain a single fixed polymerase at the bottom (Levene et al., 2003; Ardui et al., 2018a). This allows a single DNA molecule, which is circularized in the library
preparation (i.e., the SMRTbell), to progress through the well as the polymerase incorporates labeled bases onto the template DNA. Incorporation of bases induces
fluorescence that can be recorded in real-time through the transparent bottoms of the ZMW (Levene et al., 2003; Ardui et al., 2018a; Pollard et al., 2018). The
average read length for SMRT was initially only ∼1.5 Kb, and with reported high error rate of ∼13% characterized by false insertions (Carneiro et al., 2012; Quail
et al., 2012). However, the errors are randomly distributed across the reads (Eid et al., 2009) and high consensus sequences can be obtained with sufficient read
depths (Roberts et al., 2013; Hebert et al., 2018). Also, for a single molecule, with ∼10 kb read length, each nucleotide position in a 1kb amplicon can be read ∼10
times using circular consensus sequence (CCS) method, rendering it unlikely that a same random mistake would occur in multiple reads (Travers et al., 2010;
Hestand et al., 2016). Since its introduction, the read length and throughput of SMRT technology have substantially increased. Throughput can reach >10 Gb per
SMRT cell for the Sequel machine, while the average read length for both RSII and Sequel is >10 kb with some reads spanning >100 kb (van Dijk et al., 2018). Still,
the persisting downsides for this technology are the high cost/throughput ratio and the requirement of relatively high amounts of high quality DNA as starting material
(Ardui et al., 2018a; van Dijk et al., 2018).
Nanopore sequencing by ONT
As an alternative, scientist have since many years aimed to use biological or synthetic nanopores to read the sequence of DNA molecules (Kasianowicz et al., 1996;
Butler et al., 2008). In 2015, nanopore sequencing was commercially introduced by ONT with a portable MinION sequencer, which was followed by more
high-throughput desktop sequencers GridION and PromethION. The basic principle of nanopore sequencing is to pass a single strand of DNA molecule through a
nanopore which is inserted into a membrane, with an attached enzyme, serving as a biosensor (Deamer et al., 2016). Changes in electrical signal across the
membrane are measured and amplified in order to determine the bases passing through the pore in real-time. The nanopore-linked enzyme, which can be either a
polymerase or helicase, is bound tightly to the polynucleotide controlling its motion through the pore (Deamer et al., 2016; Pollard et al., 2018). For nanopore
sequencing, there is no clear-cut limitation for read length, except the size of the analyzed DNA fragments. On average, ONT single molecule reads are >10 kb in
length but can reach ultra-long for some individual reads lengths of>1 Mb surpassing SMRT (Jain et al., 2018). Also, the throughput per run of ONT GridION and
PromethION sequencers are higher than for PacBio (up to 100 Gb and 6 Tb per run, respectively) (van Dijk et al., 2018). The raw reads have high error rates similar
to SMRT dominated by false deletions and in particular homopolymer errors (Jain et al., 2015; Menegon et al., 2017). Currently, the errors are more systematic, and
are related to the length and type of the DNA fragment in the nanopore itself, and thus may not all be overcome by just increasing the coverage as with SMRT
sequencing (Krishnakumar et al., 2018).
The main limitations of current LRS technologies
Library preparation: for optimal LRS, fresh material or even intact cells are required. The DNA isolation protocols that are needed and the handling of ultra-long
high molecular weight DNA require improvements.
Error rate: both LRS technologies still have a higher error rate compared to SR-NGS. SMRT sequencing may overcome this with CCS also for long-insert libraries
(Wenger et al., 2019). It remains to be seen whether this is sufficient for all variant types including SNVs and indels. So far, ONT has more systematic error-profile,
which may be more challenging to overcome.
Costs: while LRS is still more expensive than SR-NGS, recent advancements in throughput may offer even lower prices. ONT’s PromethION already offers 30×
coverage WGS for less than 1,000 dollars, and PacBio’s 8M chip should also significantly reduce the price per human genome. It is also important to realize that the
pricings are constantly changing in this rapidly developing field:
https://docs.google.com/spreadsheets/d/1GMMfhyLK0-q8XkIo3YxlWaZA5vVMuhU1kg41g4xLkXc/htmlview?hl=en_GB (documentation of updated sequencing
costs by Dr. A Vilella).
Data analysis: both raw data analysis as well as mapping and variant calling tools are much less mature for LRS than SR-NGS but are constantly being improved
(Sedlazeck et al., 2018a).
and their frequency in WGS is even much higher than for the
>50 bp SVs (Chaisson et al., 2019). In addition to PacBio and
ONT, synthetic LRS (i.e., by 10× Genomics) can be highly useful
in SV detection (Nazaryan-Petersen et al., 2018; Marks et al.,
2019). Uncovering SVs and indels comprehensively holds the
potential to unravel a number of novel disease causing mutations
underlying human diseases.
Sequencing Tandem Repeat Expansions
A short tandem repeat is a region of genomic DNA with multiple
adjacent copies of short (1–6 bp) sequence units. These repeat
regions are highly mutable due to replication errors that occur
during cell divisions and to date over 30 human diseases known
to be caused by tandem repeat expansions (Tang et al., 2017) or
repeat contractions (Lemmers et al., 2018). Since their discovery,
the research of tandem repeat expansions has been limited by
the overall incompliance of these genomic elements to standard
molecular techniques like cloning, PCR and sequencing (Loomis
et al., 2013). Most of the disease causing expansions are longer
than the currently used NGS reads, making it virtually impossible
to accurately assemble those (Treangen and Salzberg, 2011; Lee
et al., 2016; Sedlazeck et al., 2018a). Multiple studies have now
shown that LRS technologies are well suited to transcend through
these long, often GC-rich, repeat expansions (Table 1). This
not only allows the direct detection of expansion lengths, but
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also the intra-molecule sequence variation, which might provide
clinically relevant additional information (Ardui et al., 2018b;
Cumming et al., 2018; Hoijer et al., 2018; McFarland et al., 2015).
The first tandem repeat associated disease studied by LRS was
Fragile-X (Loomis et al., 2013), which is caused by CGG-repeat
expansion in the 5′UTR of the FMR1 gene (Kremer et al., 1991).
With standard DNA sequencing technologies, i.e., SR-NGS and
Sanger sequencing, it has been impossible to directly sequence the
expanded CGG-repeats, consisting of>200 units at full mutation
range (Nolin et al., 2003; Peprah, 2012). SMRT technology
enabled for the first time to completely sequence expanded full
mutation FMR1 alleles, up to 750 CGG-repeats, which translates
to >2 kb of 100% CGG-repeat DNA (Loomis et al., 2013).
The obtained sequencing data and phasing information further
allowed to define the presence of ‘AGG’ interruptions, which
affect the risk of a premutation to expand into a full mutation
in the following generation (Nolin et al., 2015; Ardui et al., 2017).
The clinical use of this information has been largely neglected due
to technical limitations, which can now be overcome with LRS
(Ardui et al., 2018b). Genetic variation within repeat expansion
loci that are causative for other diseases, such as myotonic
dystrophy 1 (DM1) and spinocerebellar ataxia 10 (SCA10),
have also been investigated with LRS technology (Cumming
et al., 2018; McFarland et al., 2015). In DM1, SMRT sequencing
detected de novo repeat interruptions at DMPK expansion
locus, associated with reduced somatic instability of the repeat
expansion and therefore mild or even absent clinical features
(Cumming et al., 2018). Moreover, McFarland et al. (2015)
demonstrated that SMRT sequencing could identify interruption
motifs, potentially acting as phenotypic modifiers, within the
tandem repeat expansion locus in ATXN10 of SCA10 patients.
The presented studies on repeat expansions rely on PCR-
based target enrichment, which may complicate the analysis due
to the occurrence of PCR stutter, chimeric molecules, and false
insertions or deletions of the repeat units (Laver et al., 2016;
Tsai et al., 2017; Hoijer et al., 2018). Therefore, it has been
proposed that the optimal approach to study these repetitive
regions would be to sequence single DNA molecules without
any prior PCR amplification (Hoijer et al., 2018). For this, Tsai
et al. (2017) have developed CRISPR/Cas9-based amplification-
free target enrichment method (No-Amp targeted sequencing,
Table 2), which was used to capture repeat the expansion
locus in Huntingtin (HTT), responsible for Huntington’s disease
(Hoijer et al., 2018). This allowed the retrieval of detailed
sequence information and assessment of somatic variability of
repeat elements without the interference of PCR stutter. In
addition, No-Amp approach has been utilized to successfully
sequence across C9orf72 and ATXN10 repeat expansion loci in
patients with frontotemporal dementia or Parkinson’s disease,
respectively (Schule et al., 2017; Ebbert et al., 2018). These studies
indicate that No-Amp Targeted sequencing could provide an
optimal targeted solution to study different repeat elements that
are recalcitrant to PCR-based methods.
In the era of CRISPR/Cas9 genome editing, LRS has found
use in monitoring the efficiency of editing challenging genomic
regions. Dastidar et al. (2018) excised a disease causing tandem
repeat expansion in the DMPK locus in DM1 patient-derived cell
lines and used SMRT sequencing to monitor the efficiency of the
excision. In the future, LRS could be more broadly implemented
in genome editing of challenging regions. Moreover, with
the capability of directly sequencing through long tandem
repeats, LRS technology is already accelerating the discovery and
characterization of novel repeat expansions linked to human
diseases. So far, this has been demonstrated in familial forms
of epilepsy, bipolar disorder and schizophrenia (Ishiura et al.,
2018; Song et al., 2018; Zeng et al., 2018). It is noted that,
while the current approaches still largely rely on targeted
enrichment of suspected repeat expansion loci, ultimately the
analysis of all repeat-expansions genome-wide will be retrieved
directly by WGS with long reads (De Roeck et al., 2018;
Chaisson et al., 2019).
Haplotype Resolution With Long Reads
Phasing refers to the means of assigning genetic variants to the
homologous paternal and maternal chromosomes. In medical
genetics, phasing is very important for understanding, e.g.,
inheritance patterns, parental origin of de novo mutations,
mosaicism, allele-specific expression and disease risk-haplotypes
(Tewhey et al., 2011). However, in order to directly resolve
the haplotype of two heterozygous SNVs they would need to
be covered by the same molecule (i.e., read). With SR-NGS
this is usually only the case for a limited number of variants
(20–30% of substitutions), despite the use of paired-end reads
(Goldmann et al., 2016). Therefore, phasing has largely been
based on parental genotypes and statistical imputation (Tewhey
et al., 2011) or, in some cases, laborious physical separation
of entire chromosomes (Fan et al., 2011). Now, with the
substantially longer read lengths, LRS technology enables to
directly phase variants multiple kbs apart (Laver et al., 2016)
or even assemble and phase complex genomic regions, such as
the major histocompatibility complex, in full-length in a diploid
human genome (Jain et al., 2018).
Knowing whether two variants in the same gene are in
cis or trans can be crucial for diagnostic purposes, especially
for compound heterozygosity, which is a commonly observed
phenomenon underlying recessive Mendelian disorders (Tewhey
et al., 2011). By using LRS, two SNVs in the same gene can
be directly phased without the need of testing the parents
(Laver et al., 2016) or if one of the two mutations has occurred
de novo and the parental genotypes cannot resolve the phase
in the offspring (Neveling et al., 2012). In pre-implantation
genetic diagnostics (PGD), LRS can be applied to determine
the parental origin of pathogenic de novo mutations by simply
sequencing across the adjacent variants (Wilbe et al., 2017).
Resolving the parental origin of de novo mutations is needed
for estimating the recurrence risk of a genetic disease in the
case of germline mosaicism (Dimitriadou et al., 2017). LRS
could also be used in PGD to directly phase parental genotypes
for genome-wide haplotype reconstruction of a single cell via
discrete SNP genotypes (i.e., haplarithmisis) (Zamani Esteki et al.,
2015). Moreover, phasing with long reads offers an accurate
method to study mosaicism. This has recently been shown by
Gudmundsson et al. (2017) who used SMRT to resolve allele
phasing in an exceptional case of keratitis-ichthyosis-deafness
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TABLE 2 | Different applications of LRS technology.
LR-WGS
SMRT-WGS De novo assembly and reference-based WGS with focus on structural variant calling (Chaisson et al., 2015a; Seo et al.,
2016; Shi et al., 2016).
ONT-WGS De novo assembly and reference-based WGS utilizing ultra-long reads to improve phasing and close gaps in the
reference genome (Jain et al., 2018).
Targeted LRS
LR-PCR amplicon sequencing Commonly used targeted approach with standard LR-PCR amplification of the target region followed by SMRT
amplicon sequencing (Borras et al., 2017; Frans et al., 2018)
Hybridization-based capture As for SR-NGS, hybridization-based target capture can be applied for LRS (Wang et al., 2015). Protocols are available
for different vendors of bait-libraries.
No-Amp targeted SMRT sequencing A standard PacBio SMRTbell library is created and a Cas9 guide RNA is designed adjacent to the region of interest.
Digestion with Cas9 breaks open the SMRTbell molecules to enable ligation with a capture adapter. SMRTbell
molecules that contain the capture adapter are enriched on magnetic beads and prepared for SMRT Sequencing (Tsai
et al., 2017; Hoijer et al., 2018).
CATCH for ONT sequencing CATCH (Cas9-assisted targeting of chromosome segments) is based on targeted fragmentation of DNA in vitro by
Cas9, followed by separation of the target region from the rest of the genomic DNA by pulsed field gel electrophoresis
and DNA isolation from the gel (Jiang et al., 2015; Gabrieli et al., 2018)
ONT Read until selective sequencing Real-time data analysis that enables the selection of specific DNA molecules for sequencing by reversing the driving
voltage across individual nanopores: this enables to proceed to sequence only molecules that are recognized to
originate from a certain chromosome or region of interest (Loose et al., 2016).
LR-RNA-sequencing
SMRT-IsoSeq The IsoSeq method of PacBio enables sequencing of full-length transcripts up to 15 Kb using SMRT sequencing, in
turn eliminating computational transcript reconstruction and the need for a reference genome.
Direct ONT RNA-seq By circumventing the bias prone elements in regular RNA sequencing, i.e., reverse transcription and PCR amplification
of cDNA, Nanopore’s direct RNA-seq enables the direct detection of full-length RNA. This real-time single-molecule
method is based on two adapters; (1) a poly(T)adaptor for recognition and binding of the polyadenylated messenger
RNA, and (2) a pair of sequencing adaptors that ligate onto the overhang of the poly(T)adaptors and facilitate its capture
by a nanopore (Garalde et al., 2018).
R2C2 method for ONT Rolling Circle Amplification to Concatemeric Consensus (R2C2) method enables to generate a consensus from a single
sequence read with many copies of an original molecule: this approach has been used to accurately produce full-length
RNA transcript isoforms (Volden et al., 2018).
FIGURE 2 | Applicability of long-read sequencing (LRS) to unveil the transcriptome landscape of cells and tissues. Given the significant improvements in read length,
employing LRS on RNA level now allows for full-length isoform sequencing, covering the complete mRNA transcript in one single read (panel 1). As recent advances
have demonstrated the isoform landscape to be more complex than initially thought, LRS holds the potential to identify novel isoforms (panel 2), as well as detect
transcriptional and post-transcriptional modification sites, e.g., alternative transcriptional start sites (TSS), alternative splicing of exons and alternative transcription
termination sites (3′polyadenylation sites; PAS), that underpin the emergence of different isoforms (panel 3). Collectively, uncovering the full isoform diversity within
cells and tissues.
syndrome exhibiting revertant mosaicism, a rare phenomenon
involving spontaneous correction of a pathogenic mutation by
another mutation in a somatic cell. To keep in mind, Laver
et al. (2016) pointed out problems in resolving allele phasing
with targeted SMRT amplicon sequencing. In their study, the
formation of chimeric molecules during PCR-amplification led
to unambiguous results, which could have been avoided by
using PCR-free methods (Ebbert et al., 2018; Hoijer et al., 2018).
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However, these methods can be costly and time consuming and
simply keeping the amount of PCR cycles as low as possible could
offer an easier solution (Laver et al., 2016).
Identification of SVs may also benefit from phasing (Seo
et al., 2016; Cretu Stancu et al., 2017), in particular SV calling
in cancer genomes can be significantly improved to understand
the complexity of chromosomal rearrangements (Nattestad et al.,
2018). Furthermore, phasing with LRS can be used to reveal
the subclonal heterogeneity in malignancies (Lode et al., 2018).
For genome-wide association studies (GWAS), multi-allelic
haplotype markers can provide superior power compared to
single-SNP markers in mapping disease loci (Akey et al., 2001;
Khankhanian et al., 2015). However, the implementation of
haplotype-based GWAS is highly dependent on capability to
phase alleles (He et al., 2011). Therefore, LRS could be utilized
to fine-map genetic associations within regions of interest that
have previously been identified by GWAS. In addition to these
multiple situations where accurate phasing is of great importance,
LRS technology and the emerging ultra-long reads (>100 kb)
from latest LRS developments may eventually produce fully
phased diploid genomes (Pendleton et al., 2015; Seo et al., 2016;
Jain et al., 2018; Chaisson et al., 2015b), which can even originate
from single cells (Hills et al., 2018). This would allow for research
that fully leverages phase information in order to understand how
phenotypes are influenced by unique haplotype combinations
(Tewhey et al., 2011).
Pseudogenes
Pseudogenes usually originate from gene duplication or
retrotransposition events and are defined as sequences that
resemble known functional genes but cannot produce functional
proteins (D’Errico et al., 2004). Notably, the GENCODE project
has estimated that the human genome contains more than
14,000 pseudogenes (Pei et al., 2012) and many clinically relevant
genes (such as PMS2, CYP2D6, CHEK2, SMN1, and PKD1)
are known to have pseudogenes with high sequence homology
(Mandelker et al., 2016). This has significant consequences
for re-sequencing studies as pseudogenes may severely impair
reliable variant identification in their functional counterparts
(Claes and De Leeneer, 2014) and lead to false diagnostic test
results (Bardaro et al., 2003). Traditional methods, such as
SR-NGS may capture sequences from pseudogenes in addition
to the functional genes, leading to mapping errors, low variant
detection rates and high number of false positives (Claes and
De Leeneer, 2014). Other issues originate from the fact that
some pseudogene sequences are still missing from the human
reference genome and may cause mapping issues for SR-NGS
(Karakoc et al., 2011). Therefore, assays based on SR-NGS may
not always be reliable for investigating genes that have highly
homologous pseudogenes.
To date, several studies (Table 1) have utilized LRS in
order to investigate clinically relevant genes with homologous
pseudogenes (Ammar et al., 2015; Qiao et al., 2016; Borras
et al., 2017; Buermans et al., 2017; Frans et al., 2018). These
studies have largely relied on target enrichment with long-range
PCR (LR-PCR) using primers that locate to the rare mismatch
sites that distinguish the gene of interest from its pseudogenes
(Frans et al., 2018). Similar approaches have been used with
Sanger sequencing and SR-NGS. However, with LRS, the reads
can span the complete LR-PCR amplicon and retain the phase
information (Buermans et al., 2017). Furthermore, reference-
free assembly of long reads can circumvent errors that may be
introduced by complex or repetitive regions in the reference
genome (Borras et al., 2017). For example, Polycystin 1 (PKD1),
responsible for autosomal dominant polycystic kidney disease,
has traditionally been challenging to analyze with NGS or
Sanger sequencing because of its high GC-content, large size
and homology with pseudogenes (Tan et al., 2014). Borras et al.
(2017) demonstrated that by coupling LR-PCR with SMRT, the
interference of residual PKD1 pseudogene amplification and
alignment ambiguities could be eliminated, and SVs could be
identified. In addition, multiple studies have demonstrated the
utility of LRS for genotyping and phasing CYP2D6, which is
one of the most important genes involved in drug metabolism,
but has been difficult to analyze by conventional methods due
to homologous pseudogenes and complex gene rearrangements
(Ammar et al., 2015; Qiao et al., 2016; Seo et al., 2016;
Buermans et al., 2017).
For medical genetics research, it is crucial to have reliable
information on the population frequencies of particular gene
variants in order to assess their potential pathogenicity (Ashley,
2016). For this, databases such as ExAC and GnomAD are often
used (Lek et al., 2016). However, reference datasets attained with
SR-NGS might be problematic for genes with highly homologous
pseudogenes. This is mainly because: (1) the deposited variants
may be derived from pseudogenes, (2) true variants might stay
undetected or (3) the gene of interest might be ambiguously
covered (Mandelker et al., 2016). Long reads could be used
to improve the annotation of duplicated regions because they
harbor sufficient number of paralogous sequence variants to
confidently assign them to their respective paralogs (Dougherty
et al., 2018). Therefore, in addition to more reliable pseudogene
discrimination, LRS can be used to generate more accurate
reference datasets and annotations for many challenging genes,
subsequently allowing improvements in variant interpretation.
UNCOVERING THE TRANSCRIPTOME
LANDSCAPE TO AID GENETIC
DIAGNOSIS
The emergence of NGS, together with the incessancy of
technological advances, drives our increasing ability to uncover
complex and previously ‘hidden’ genetic aberrations, however,
our current capacity to interpret their functional and clinical
impact remains restrained. By providing a global transcriptomic
profile, both quantitatively, i.e., gene expression levels, and
qualitatively, i.e., transcript sequences and isoform structures,
RNA sequencing holds the potential to reduce this diagnostic
gap significantly. Recently two research groups pioneered this
technology as a complementary tool to DNA-based tests and
demonstrated its value in the detection of both coding and
non-coding variants (Cummings et al., 2017; Kremer et al.,
2017). In particular, authors identified a variety of variants
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underpinning (1) abnormal or mono-allelic expression and
(2) aberrant splicing, resulting in the creation, skipping and
truncation of exons, as well as exon and intron retention, even
in regions harbouring repetitive regions. In turn, resulting in
a diagnostic yield ranging from 10% for mitochondriopathies
to 21% for primary muscle disorders in patients lacking
strong candidates from WES or WGS (Cummings et al., 2017;
Kremer et al., 2017).
Similar to NGS-based genomic approaches, however, short-
read RNA sequencing methodologies are limited by their need
for computational reconstruction of individual short reads into
complete transcripts (Steijger et al., 2013). With the advent
of long-read RNA sequencing the accurate identification and
quantification of full-length mRNA transcript isoforms has
become possible (Figure 2). A comparative approach by Anvar
et al. (2018) has revealed up to 17% of novel alternative
exons to be detected following long-read RNA sequencing of
three primary human tissues, i.e., brain, heart, liver, thereby
corroborating the isoform landscape to be more complex than
initially thought (Sharon et al., 2013; Tilgner et al., 2013).
In addition, the authors demonstrate the applicability of full-
length mRNA sequencing to uncover transcriptional regulation
and post-translational modification profiles, including alternative
transcription initiation, allele specific alternative splicing and
alternative 3′ termination (polyadenylation) (Anvar et al., 2018).
The clinical significance of integrating this transcriptomic data
was exemplified by Aneichyk et al. (2018), who identified
an intronic retrotransposon to induce alternative splicing that
subsequently affects TAF1 expression, in turn causing X-linked
Dystonia-Parkinsonism. Moreover, by exploring long-read RNA
sequencing in the characterization of premature termination
codons in ABCA7 in late-onset Alzheimer’s disease, De Roeck
et al. (2017) observed various degrees of nonsense-mediated
decay (NMD) and transcript modification that potentially
influence ABCA7 dosage and disease severity. While the ultimate
goal may be to employ this technique to allocate the causative
variant and map its functional impact on a patient-level, there
may already be a major improvement by sequencing reference
sets of tissue/cell specific RNA-isoform landscapes. Gaining
insight into the isoform landscape of disease relevant tissues or
cell types, potentially even on a single-cell level (Byrne et al.,
2017; Gupta et al., 2018), will advance the overall interpretation
of clinical significance of complex rearrangements (Nattestad
et al., 2018), tissue-specific isoforms (Clark et al., 2018) and splice
variants (de Jong et al., 2017). Ultimately, this knowledge can
be implemented to improve WES/WGS-based variant filtering,
prioritization and prediction of their functional impact.
FUTURE PERSPECTIVES AND
CONCLUSION
Most of the clinically relevant examples described in this review
use targeted LRS approaches, indicating that the broader use of
LRS could significantly increase the diagnostic yield of genetic
testing and discover novel disease genes. Especially SVs, repetitive
elements and complex genomic regions that are difficult to assess
with short reads can now be better assessed. LRS technology
is also changing our view on the mRNA isoform landscape of
different tissues and genes, potentially enabling better functional
interpretation of genomic variation in the future. It is noted that,
while the currently used LRS technologies are not quite yet at
the stage of individual fully phased de novo assembled genomes,
but with increased throughput, higher accuracy and lower costs,
LRS-based WGS is coming within reach. Once this is routine,
we are foreseeing the possibility that WGS with long reads could
serve as a truly generic test that enables to detect all genetic
variants present in an individual’s genome. Then the power of
LRS to overcome the current limitations in medical genetics
may be elucidated at fast pace. Moreover, systematic studies
utilizing LRS in patient cohorts with unsolved genetic diseases
and control populations are warranted, and several consortia,
e.g., www.solve-rd.eu or http://www.internationalgenome.org/
1000-genomes-browsers, have already announced the use of
LRS-WGS for this.
While the medical genetics community is now starting to
realize the potential of this technology, some obstacles need
to be overcome in order for LRS to be established as a
mainstream tool (for overview of LRS limitations, see Box 1).
Especially library preparation and analysis still need to reach the
high level of robustness of SR-NGS technologies. For the data
analysis, bioinformatic tools have traditionally been optimized
for short-read sequencing data and need to be adapted, as well
as thoroughly tested, for long reads (Sedlazeck et al., 2018a).
In addition, analyzing whole genomes with LRS is still very
expensive and the future application will depend largely on
pricing progress of all NGS technologies, and may also depend
on how fast the short-reads can reach an even lower prices with
even better quality (i.e., the ∼100$ genome). Eventually, one
might need to consider a choice between sequencing many less-
expensive genomes with short-reads as opposed to investigating
a smaller number of genomes in-detail using long reads. It
is not a straightforward decision to make, however, the latter
option would ideally be beneficial for an individual patient
in clinical diagnostics. Combining SR-NGS and LRS can also
be a powerful approach for highly accurate variant calling
and assembly (Chaisson et al., 2019) and become increasingly
important and more easily available with the planned acquisition
of PacBio by Illumina.
We foresee that both of the prevailing LRS technologies,
PacBio and ONT, will have a major influence on the future of
medical genetics. ONT has the potential to become low in price,
ease of use technology that is capable of directly investigating
both native DNA and RNA in a high-throughput manner.
The main challenge for ONT technology is to circumvent the
systematic error rate, e.g., for homopolymer regions, which
may be a limitation especially for future diagnostic applications.
ONT has put forward ideas to improve this by optimizing
bioinformatic tools that allow more accurate repeat lengths
measurements and proposed to leverage different types of
nanopores. One possible improvement was already enabled
by the rolling circle amplification to concatemeric consensus
method (R2C2) (Volden et al., 2018). For SMRT sequencing,
the consensus accuracy achieved is better, especially once
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intra-molecule consensus – in addition to the existing
inter-molecule consensus – calling is also feasible for long-
insert libraries. To enable human genome sequencing,
throughput needs to go up. To this end, PacBio has recently
announced to release a SMRT cell with 8 million ZMWs
in 2019 (∼8-fold increase) and other improvements may
come from even longer read lengths. This would enable
much higher throughput and reduction in sequencing costs.
Altogether, it remains to be seen whether the quality of
the LRS technologies is sufficient for genome-wide detection
of small indels and SNVs. If so, PacBio and ONT will
have a chance to become the platform for true WGS for
population scale studies in the near future. Moreover, the
native epigenetic modifications of the DNA are preserved in
PCR-free single molecule sequencing, opening up possibilities
for novel LRS-based applications to assess base modifications
(Pham et al., 2016; Euskirchen et al., 2017).
In addition to already commercially available technologies
discussed in this review, others are in active development
and will hopefully be available for users in the future. These
include novel nanopore-based technologies from Genia (now
acquired by Roche) and Stratos Genomics (Carson and
Wanunu, 2015; Fuller et al., 2016), or the Electronic Nano-
Device sequencing (ENDSeq) from Roswell Biotechnologies
(Pugliese et al., 2015). Other exciting technologies that
may also provide long-read insights are, e.g., library-and
amplification-free technology from Nanostring (Hyb & Seq),
nanochannel genome mapping technology from Bionano
Genomics (Lam et al., 2012; Seo et al., 2016) and Strand-Seq
that preserves long-range context of homologous chromosomes
(Sanders et al., 2017; Ghareghani et al., 2018). Whether these
or other technologies are complementary to the existing LRS
approaches, or may be able to compete with or even replace
PacBio and ONT remains to be seen.
To conclude, we are on the advent of next revolution in
sequencing technology. Once the major obstacles regarding
accuracy, analysis and pricing are overcome, the time would be
right to move towards individual fully phased long-read genomes,
likely based on individual de novo assemblies that enable the
identification of all the genetic variants regardless of their type.
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